je.st
news
Sun Pharma denies its units role in 24 surge in Ranbaxy shares
2014-05-05 22:28:29| Chemicals - Topix.net
Sun Pharmaceutical Industries Ltd, which is set to buy rival drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, said its unit Silverstreet Developers LLP had no role to play in the run-up in Ranbaxy shares ahead of the deal announcement in April.
Tags: role
sun
units
shares
Category:Chemicals